Literature DB >> 21934127

Radiofrequency inferior turbinate reduction: long-term olfactory and functional outcomes.

Massimiliano Garzaro1, Matteo Pezzoli, Vincenzo Landolfo, Simona Defilippi, Carlo Giordano, Giancarlo Pecorari.   

Abstract

OBJECTIVE: The aim of this study was to assess the long-term effects of radiofrequency inferior turbinate reduction (RITR) on nasal function in patients affected by nasal obstruction secondary to turbinate hypertrophy, focusing attention on increased sense of smell and its persistence after a 2-year follow-up. STUDY
DESIGN: Case series with planned data collection.
SETTING: ENT division, university hospital. SUBJECTS AND METHODS: A total of 40 consecutive patients undergoing RITR for allergic or nonallergic chronic rhinitis with inferior turbinate hypertrophy were included. We planned a series of tests, including the "Sniffin' Sticks" test battery, anterior rhinomanometry, and the nasal Obstruction Symptom Evaluation (NOSE) scale, on the day of the procedure and at the 2-month and 2-year follow-up visits.
RESULTS: Of the 40 patients, 35 completed all the objective and subjective examinations on the day of the procedure and at the 2-month and 2-year follow-up visits. The authors found a significant decrease in nasal resistances from a mean of 1.13 Pa/cm(3)s(-1) preoperatively to a mean of 0.29 Pa/cm(3)s(-1) 2 years postoperatively and improvement in odor threshold, discrimination, and identification scores 2 years postoperatively. The NOSE score diminished significantly 2 years after surgery from a mean of 23.14 to a mean of 4.14 (all P < .01 with the t test for repeated measures).
CONCLUSION: This long-term evaluation showed that radiofrequency treatment for allergic or nonallergic inferior turbinate hypertrophy appeared to provide improvement in olfaction, decrease nasal resistances, and have subjective benefits, maintained 2 years after the procedure.

Entities:  

Mesh:

Year:  2011        PMID: 21934127     DOI: 10.1177/0194599811423008

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  7 in total

1.  Grade 4 tonsillar hypertrophy associated with decreased retronasal olfactory function: a pilot study.

Authors:  Melih Cayonu; Murat Salihoglu; Aytug Altundag; Hakan Tekeli; Gürkan Kayabasoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-09       Impact factor: 2.503

2.  A randomized study of temperature-controlled versus bipolar radiofrequency for inferior turbinate reduction.

Authors:  Wish Banhiran; Paraya Assanasen; Pongsakorn Tantilipikorn; Nongyoa Nujchanart; Siriporn Voraprayoon; Chaweewan Bunnag
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-29       Impact factor: 2.503

3.  Long-Term Outcomes of Radiofrequency Ablation of the Inferior Turbinates.

Authors:  Casey Means; Macario Camacho; Robson Capasso
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-09-25

4.  Long-term self-reported treatment effects and experience of radiofrequency-induced thermotherapy of the inferior turbinates performed under local anesthesia: a retrospective analysis.

Authors:  F Safiruddin; A V M T Vroegop; M J L Ravesloot; N de Vries
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-02       Impact factor: 2.503

5.  Radiofrequency volumetric inferior turbinate reduction: long-term clinical results.

Authors:  E De Corso; G Bastanza; V Di Donfrancesco; M L Guidi; G Morelli Sbarra; G C Passali; A Poscia; C de Waure; G Paludetti; J Galli
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-06       Impact factor: 2.124

6.  The Long-term Effect of Inferior Turbinate Surgery Techniques on Nasal Obstruction and Quality of Life.

Authors:  Teemu Harju; Jura Numminen
Journal:  Ann Otol Rhinol Laryngol       Date:  2021-10-06       Impact factor: 1.973

7.  Intranasal corticosteroids for non-allergic rhinitis.

Authors:  Christine Segboer; Artur Gevorgyan; Klementina Avdeeva; Supinda Chusakul; Jesada Kanjanaumporn; Songklot Aeumjaturapat; Laurens F Reeskamp; Kornkiat Snidvongs; Wytske Fokkens
Journal:  Cochrane Database Syst Rev       Date:  2019-11-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.